Thyroxine increased in Rescriptor - how severe and when it was recovered? (a real world drug study)
Summary:
There is no report of severity or recovery of Thyroxine increased by people who take Rescriptor yet.
What is Rescriptor?
Rescriptor has active ingredients of delavirdine mesylate. eHealthMe is studying from 426 Rescriptor users. Check the latest studies of Rescriptor.
What is Thyroxine Increased?
Thyroxine increased is found to be associated with 96 drugs and 222 conditions by eHealthMe. Check the latest studies of Thyroxine increased.
No report is found.
Do you take Rescriptor and have Thyroxine increased?
Check whether Thyroxine increased is associated with a drug or a conditionHow to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
How the study uses the data?
The study is based on delavirdine mesylate (the active ingredients of Rescriptor). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Invega and Completed Suicide for Men aged 20-29 - 10 seconds ago
- Drug interactions of Extraneal and Ramipril - 10 seconds ago
- Drug interactions of Clotrimazole and Bydureon - 14 seconds ago
- Freezing Phenomenon and drugs of ingredients of istradefylline - 22 seconds ago
- Nasonex and Lomotil drug interactions for women aged 50-59 - 25 seconds ago
- Coq vs. Losartan, side effect and effectiveness comparison - 42 seconds ago
- Etoposide and Hair Loss for Women aged 50-59 - 57 seconds ago
- Etoposide and Hair Thinning for Women aged 50-59 - 57 seconds ago
- Etoposide and Loss Of Hair for Women aged 50-59 - 57 seconds ago
- Etoposide and Hairloss for Women aged 50-59 - 58 seconds ago